Philadelphia, PA -
NephCure Foundation Executive Director Henry Brehm has
announced the hiring of Marilyn Hailperin as Research and
Education Manager and Rob Hastings as Director of
The NephCure Foundation, based in
Berwyn, PA, is the only organization solely committed to
seeking a cause and cure for the kidney diseases Nephrotic
Syndrome and Focal Segmental Glomerulosclerosis (FSGS).
Comprised of patients, their families and friends,
researchers, physicians and other healthcare professionals,
NephCure aims to help science unlock the biological
mechanisms that cause these serious diseases and ultimately
find a way to cure and prevent them.
"These are critical roles in our
organization," said Brehm. "I believe Marilyn and Rob will
bring a level of expertise and experience NephCure that will
help us to continue to grow to new levels."
Hailperin joins NephCure after two
previous phases of a career that, when combined, make her
uniquely qualified for her new position. In her new role at
NephCure, she will combine skills and experience gained in
her first career as a scientist with the project management
and organizational development skills she acquired in the
corporate healthcare business world.
Hailperin, who resides in Cherry
Hill, NJ, received her B.S. from the University of
Pennsylvania and her M.S. in Clinical Microbiology from
Thomas Jefferson University School of Graduate Studies. She
worked as the Assistant Microbiologist for the Pepper
Laboratories of the Department of Pathology at the Hospital
of the University of Pennsylvania for several years and
participated in peer reviewed Bacteriology and Virology
After leaving Penn, Hailperin spent
the next 20 years as a management consultant and executive
of several healthcare information technology services firms.
She specialized in building lines of business around
Hastings comes to NephCure with a
background that includes considerable non-profit fundraising
experience as well as extensive knowledge of finance and
business. His focus with NephCure will be on securing major
gifts from individuals, corporations and foundations. A
primary objective will be the launch of NephCure's "Got
Hope" campaign, which seeks to raise $5 million over the
next several years.
Hastings has raised money for several
non-profit organizations in the suburban Philadelphia area.
For the last three years, he has served as the Chair of the
Alumni Annual Fund at The Haverford School in Haverford, PA.
He also serves on The Bryn Mawr Hospital Foundation Board,
the Parent Fund Council at The Agnes Irwin School, and has
run several campaigns for St. David's Church (Radnor, PA).
Most recently, he joined The Haverford School Board of
A Rosemont, PA resident, Hastings
has worked in operations, credit analysis, and trust
administration for JP Morgan Securities, Deutsche Bank Trust
Company, and most recently, Hirtle, Callaghan & Co.
Nephrotic Syndrome and FSGS are
conditions that affect the tiny filtering mechanisms in the
kidney. Over time this condition can result in renal
failure and the need for dialysis or a kidney transplant.
The cause for Nephrotic Syndrome and FSGS is not known, and
there is no cure. There are over 5,000 new diagnosis of FSGS
Because of privacy laws, The NephCure
Foundation has a unique challenge in finding families
affected by Nephrotic Syndrome and FSGS. Therefore, in
addition to fundraising for research, The Nephcure
Foundation devotes much of its efforts to identifying and
educating patient families. Further information for families
or potential supporters can be obtained at
http://www.nephcure.org/ or by contacting Nadia